Stem cell treatment for high-risk HPV infection
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests whether umbilical cord stem cells can help clear a persistent high-risk HPV infection. It is for women aged 25 to 60 who have had HPV for a while and have not been treated with other HPV drugs recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 60 years old and have been sexually active for more than 2 years.
- You have a confirmed high-risk HPV infection that has lasted for some time.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You have not had any anti-HPV drugs or other treatments for HPV recently.
- You are not currently in another clinical trial.
- You do not have serious immune system problems, severe allergies, or a history of cervical cancer or high-grade cell changes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 trial tests a one-time infusion of special immune T cells made to recognize your HPV16 tumor. It may help your body attack the cancer, while researchers closely monitor safety and early effectiveness.
This trial tests a new treatment using your own immune cells (called T cells) that are modified to target HPV-positive cancer cells. It may be an option if you have advanced cervical, head/neck, anal, penile, vulvar, or vaginal cancer that is HPV16 or HPV52 positive and has progressed after standard therapy.
This trial tests whether an HPV vaccine (the nonavalent type) can help prevent the same precancerous lesions from coming back after treatment. It is for people who currently have a high-grade HPV-related lesion but have not yet been treated for it.
This Phase 2 trial tests an immune-cell treatment (E7 TCR T cells) designed to attack cancers caused by HPV type 16. It may help people whose HPV-16+ cancer has come back or not responded to standard treatment.
This trial tests whether a single infusion of stem cells made from human umbilical cord tissue can help women with premature ovarian insufficiency (early menopause) by improving ovarian function and reducing menopause symptoms. Participants will continue their usual hormone replacement therapy during the study.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
Hear when a new Mesenchymal Stem Cells trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.